Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor α

被引:59
作者
Murakami, K [1 ]
Ide, T [1 ]
Suzuki, M [1 ]
Mochizuki, T [1 ]
Kadowaki, T [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Metab Dis, Tokyo, Japan
关键词
D O I
10.1006/bbrc.1999.0951
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The alpha isoform of peroxisome proliferators-activated receptor (PPAR) is activated by fatty acids, their metabolites, and the fibrate class of lipid-lowering agents. To test the ability of these activators to directly bind the ligand-binding domain of human PPAR alpha, we performed a competitive binding assay using radiolabeled [H-3]KRP-297, a known ligand for human PPAR alpha. Long-chain fatty acids and eicosanoids were even more potent ligands for human PPAR alpha than the hitherto most potent PPAR alpha ligand WY-14,643. Moreover, these natural ligands avidly activated this receptor in a transient transcriptional assay. This study provides the direct evidence that human PPAR alpha is activated through the direct binding of fatty acids and eicosanoids, as well as of a fibrate, to its ligand-binding domain. (C) 1999 Academic Press.
引用
收藏
页码:609 / 613
页数:5
相关论文
共 24 条
  • [1] Aarsland A, 1998, J LIPID RES, V39, P1280
  • [2] Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients
    Auboeuf, D
    Rieusset, J
    Fajas, L
    Vallier, P
    Frering, V
    Riou, JP
    Staels, P
    Auwerx, J
    Laville, M
    Vidal, H
    [J]. DIABETES, 1997, 46 (08) : 1319 - 1327
  • [3] HYPOLIPEMIC DRUGS ARE ACTIVATED TO ACYL-COA ESTERS IN ISOLATED RAT HEPATOCYTES - DETECTION OF DRUG ACTIVATION BY HUMAN LIVER HOMOGENATES AND BY HUMAN PLATELETS
    BRONFMAN, M
    MORALES, MN
    AMIGO, L
    ORELLANA, A
    NUNEZ, L
    CARDENAS, L
    HIDALGO, PC
    [J]. BIOCHEMICAL JOURNAL, 1992, 284 : 289 - 295
  • [4] The PPAR alpha-leukotriene B-4 pathway to inflammation control
    Devchand, PR
    Keller, H
    Peters, JM
    Vazquez, M
    Gonzalez, FJ
    Wahli, W
    [J]. NATURE, 1996, 384 (6604) : 39 - 43
  • [5] Ligand-induced peroxisome proliferator-activated receptor alpha conformational change
    Dowell, P
    Peterson, VJ
    Zabriskie, TM
    Leid, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) : 2013 - 2020
  • [6] Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity
    Dresner, A
    Laurent, D
    Marcucci, M
    Griffin, ME
    Dufour, S
    Cline, GW
    Slezak, LA
    Andersen, DK
    Hundal, RS
    Rothman, DL
    Petersen, KF
    Shulman, GI
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) : 253 - 259
  • [7] INHIBITION OF HEPATIC FATTY-ACID OXIDATION BY BEZAFIBRATE AND BEZAFIBROYL COA
    EACHO, PI
    FOXWORTHY, PS
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 157 (03) : 1148 - 1153
  • [8] Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
    Forman, BM
    Chen, J
    Evans, RM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) : 4312 - 4317
  • [9] FATTY-ACIDS ACTIVATE A CHIMERA OF THE CLOFIBRIC ACID-ACTIVATED RECEPTOR AND THE GLUCOCORTICOID RECEPTOR
    GOTTLICHER, M
    WIDMARK, E
    LI, Q
    GUSTAFSSON, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) : 4653 - 4657
  • [10] ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0